Abstract
Restriction fragment length polymorphism (RFLP) analysis, comparative marker chromosome analysis, and polymorphic enzyme analysis was carried out on a total of eight human urothelial cell lines and sublines selected according to our knowledge of their HLA-A,B phenotype. RFLP analysis and cytogenetic analysis showed that the cell lines Hu1703He, Hu1922, and T24 are genuine cell lines of different origin. The identity of Hu1703He could not be confirmed by its isozyme phenotype which was identical to the T24 phenotype. RFLP analysis and isozyme analysis revealed that three cell lines, Hu456, Hu549, and Hu961a, and two transformed sublines, HCV-29Tmv and Hu609Tmv, are sublines of T24. A common origin of Hu456, Hu549, Hu961a, HCV-29Tmv, and Hu609Tmv was confirmed by marker chromosome analysis. However, the T24 origin of these cytogenetically related cell lines was not supported by chromosome analysis of T24. RFLP analysis and HLA phenotyping of two tumorigenic and invasive sublines isolated from a culture of non-tumorigenic Hu609 cells showed that non-tumorigenic Hu609 cells can transform 'spontaneously' in vitro into tumorigenic Hu609T cells. The results emphasise the need for careful monitoring and screening of cell lines for their identity using more than one identification parameter.
Highlights
The purpose of this study was to establish the identity of tumorigenic urothelial cell lines and sublines by applying Restriction fragment length polymorphism (RFLP) analysis, isozyme analysis, and comparative marker chromosome analysis
The RFLP pattern of Hu1922 and Hul703He showed that these two cell lines were different in origin from each other and from other cell lines and sublines analysed, including non-tumorigenic cell lines (Christensen et al, submitted)
The identity of Hul703He was confirmed by marker chromosome analysis, but not by its isozyme pattern which was identical to T24, Hu96la, Hu456, Hu549, HCV-29Tmv, and Hu609Tmv
Summary
The purpose of this study was to establish the identity of tumorigenic urothelial cell lines and sublines by applying RFLP analysis, isozyme analysis, and comparative marker chromosome analysis
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have